Market intelligence analyst discusses new trends and emerging strategies in pharma revenue management, given today’s fast-evolving technological and regulatory dynamics
Nicholas Saraceno, Editor
Advertisement
Nicholas Saraceno is Editor of Pharmaceutical Commerce. He can be reached at [email protected].
Articles by Nicholas Saraceno, Editor
C-suite executive shares knowledge surrounding data security and risk mitigation
Digital healthcare company joins the magazine's first ever podcast episode
More leverage for community-based pharmacies and rules changes for drug-pricing reporting
A one-on-one with Fabian Gerlinghaus, co-founder and CEO of Cellares, who discusses the quest to overcome bottlenecks in industrial scale cell therapy manufacturing
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Novartis Buys Avidity for $12B, and Trump Threatens 10% Tariff Hike on Canada
2
LogiPharma USA 2025: Pharma Supply Chains Evolve Toward Real-Time Visibility and End-to-End Control
3
Trump Threatens 10% Tariff Hike on Canadian Imports After Controversial Reagan Ad Airs During World Series
4
Why DTC Drug Models Must Evolve From Access to True Patient Support
5
